In the recently published ‘Three-dimensional printing in structural heart disease and intervention,’ authors Yiting Fan, Randolph H.L. Wong, and Alex Pui-Wai Lee, all from The Chinese University of Hong Kong, explore the potential for 3D printing in the world of medicine, as well as cardiology—and more specifically, structural heart disease (SHD).
SHD causes issues like:
- Aortic stenosis
- Mitral regurgitation
- Atrial septal defect
- Left atrial appendage (LAA) clots
Conventional imaging is limited, while the emergence of 3D printed models allows medical professionals to progress from mentally reconstructing 2D images to gaining a more complex understanding of pathology.
As 3D printing continues to make its way into the realm of medicine, models are used for:
- Guiding treatment
- Procedural simulation
- Facilitating hemodynamic research
- Improving interventional training
- Promoting patient-clinician communication
To create a medical model, images must be attained, data must be processed, and the object must be 3D printed.
“The most commonly used imaging sources for SHD are echocardiography, computed tomography (CT) and magnetic resonance imaging (MRI),” state the researchers. “Other modalities, such as positron emission tomography, single photon emission CT and cone beam CT, are less commonly used. All images should use the common Digital Imaging and Communication in Medicine (DICOM) format.
A range of materials are both popular and possible for fabricating medical models:
“Multi-material printing by material jetting is increasingly used to create cardiac structures. Different tissue components were printed with different textures. For instance, an aortic valve was printed with flexible printing material, and the calcifications attached to valves were printed with hard printing material, respectively,” report the authors.
There continue to be ongoing challenges in the creation of medical models, however, ‘despite the enthusiasm in applying 3D printing cardiovascular medicine.’ While there is an obvious lack of technical standards, mainly due to the novelty of the technology, the authors point out also that there are still issues with affordability—along with ‘scant evidence on the added clinical benefit.’
Greater accuracy is needed, along with improved standardization of data acquisition, and post-processing techniques. While deeper research is required into the creation and use of models and surgical guides, so are comparisons for offering up better information and creating industry standards. The authors also recommended a more streamlined workflow.
“The mechanical properties of the 3D-printed materials, such as tensile strength, elasticity, flexibility, hardness, and durability have utmost importance for cardiovascular applications. The majority of cardiovascular applications reported so far have employed materials with properties that have not been meticulously compared with the cardiovascular tissue they are mimicking. Validation of 3D-printed material properties against actual human patient tissues is important to ensure that procedural simulation is realistic,” conclude the authors.
“Further effort in technical standardization, and clinical evaluation of added benefit and cost-effectiveness of 3D printing are needed to bring this promising technique to clinical reality.”
3D printed medical models are extremely beneficial to doctors and patients as they allow not only for diagnosing but have also continued to change medicine—allowing for procedures involving complex reconstructions, fabrication of surgical guides, and much more.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: ‘Three-dimensional printing in structural heart disease and intervention’]
You May Also Like
3D Printing Webinar and Event Roundup: September 12, 2021
Buckle your seatbelts, it’s going to be a busy week of webinars and events, both virtual and in-person! RAPID + TCT and FABTECH will both be held in-person this week...
Sixth Bioprinting Acquisition in One Year from Cellink Parent Company BICO
Pioneering bioprinting firm Cellink, now part of a larger company rebranded as BICO (short for bioconvergence), has already been making quite a name for itself and is preparing to capture...
Complete Tumor 3D Printed to Facilitate Faster Treatment Prediction
There are more than 120 different types of brain tumors, many of which are cancerous, but the deadliest, and sadly most common, is the aggressive, fast-growing glioblastoma multiforme (GBM), a...
3D Printing Webinar and Event Roundup: August 15th, 2021
From convincing your professor they need a 3D printer and the future of static mixers to biomaterials and bioprinting, we’ve got another week of webinars and events to tell you...
View our broad assortment of in house and third party products.